OXB Messy Chart Long OXB.L Oxford Biomedical long, double bullflag kinda pattern happening.
Bio companies still popular right now.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.5 GBP
−157.49 M GBP
89.54 M GBP
77.75 M
About OXFORD BIOMEDICA ORD GBP0.50
Sector
Industry
CEO
Frank Mathias
Website
Headquarters
Oxford
Founded
1996
ISIN
GB00BDFBVT43
FIGI
BBG000BMB7T9
Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. It operates through the following segments: Platform and Product. The Platform segment consists of the revenue generating bioprocessing and process development activities undertaken for third parties. The Product segment includes clinical and preclinical development of in vivo and ex vivo gene and cell therapy products which are owned by the group. The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom.
Breakout on OXBThe Head and Shoulders pattern since 2008 has completed.
If the breakout continues, the target is 1264p.
Backed by substantive news, makes OXB, in my opinion, a strong buy. DYOR
Target on Oxford Biomedica (monthly chart)If OXB continues to head higher, then the target
is the height of the Head in the H&S pattern
formed on the monthly chart.
Good news for Oxford BiomedicaAfter multiple tests of resistance,
it looks as if OXB is going to break 11p and move higher
$OXB A six month consolidation before a bullish move this week.$OXB A six month consolidation before a bullish move this week.
Formed a symmetrical triangle with 3 touches on each side before the breakout.
Multibag; or not?A clear breakout for OXB
However, can it sustain the upward
momentum and break past 13p and head towards 20p.
OXB heading higher?Has broken above resistance in late 2015 (1)
RSI and MACD are heading the right direction (2)
and Moving averages are in alignment (3)
OXB - Saucer formation, wait for drop back, then long.Month's in the waiting, like the look of this one now, but waiting for a drop back (handle?) in seeking the optimum entry point. Potential cross of 200MA not too far away now as time progresses. RSI & MACD turning, so good chance of seeing the drop back. 3.60 and the 50MA looks good to me. LSE:OXB
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OXB is 412.5 GBX — it has decreased by −1.08% in the past 24 hours. Watch OXFORD BIOMEDICA ORD GBP0.50 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange OXFORD BIOMEDICA ORD GBP0.50 stocks are traded under the ticker OXB.
OXB stock has risen by 3.13% compared to the previous week, the month change is a 8.55% rise, over the last year OXFORD BIOMEDICA ORD GBP0.50 has showed a 94.69% increase.
We've gathered analysts' opinions on OXFORD BIOMEDICA ORD GBP0.50 future price: according to them, OXB price has a max estimate of 740.00 GBX and a min estimate of 380.00 GBX. Watch OXB chart and read a more detailed OXFORD BIOMEDICA ORD GBP0.50 stock forecast: see what analysts think of OXFORD BIOMEDICA ORD GBP0.50 and suggest that you do with its stocks.
OXB stock is 4.89% volatile and has beta coefficient of 1.91. Track OXFORD BIOMEDICA ORD GBP0.50 stock price on the chart and check out the list of the most volatile stocks — is OXFORD BIOMEDICA ORD GBP0.50 there?
Today OXFORD BIOMEDICA ORD GBP0.50 has the market capitalization of 436.93 M, it has decreased by −2.97% over the last week.
Yes, you can track OXFORD BIOMEDICA ORD GBP0.50 financials in yearly and quarterly reports right on TradingView.
OXFORD BIOMEDICA ORD GBP0.50 is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
OXB earnings for the last half-year are −0.31 GBX per share, whereas the estimation was −0.28 GBX, resulting in a −9.50% surprise. The estimated earnings for the next half-year are −0.13 GBX per share. See more details about OXFORD BIOMEDICA ORD GBP0.50 earnings.
OXFORD BIOMEDICA ORD GBP0.50 revenue for the last half-year amounts to 50.81 M GBX, despite the estimated figure of 50.50 M GBX. In the next half-year revenue is expected to reach 78.80 M GBX.
OXB net income for the last half-year is −32.48 M GBP, while the previous report showed −109.53 M GBP of net income which accounts for 70.34% change. Track more OXFORD BIOMEDICA ORD GBP0.50 financial stats to get the full picture.
No, OXB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 714.00 employees. See our rating of the largest employees — is OXFORD BIOMEDICA ORD GBP0.50 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OXFORD BIOMEDICA ORD GBP0.50 EBITDA is −46.27 M GBP, and current EBITDA margin is −67.17%. See more stats in OXFORD BIOMEDICA ORD GBP0.50 financial statements.
Like other stocks, OXB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OXFORD BIOMEDICA ORD GBP0.50 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OXFORD BIOMEDICA ORD GBP0.50 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OXFORD BIOMEDICA ORD GBP0.50 stock shows the neutral signal. See more of OXFORD BIOMEDICA ORD GBP0.50 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.